Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06311032

Enrollment

Registered

2024-03-15

Start date

2023-03-29

Completion date

2023-07-28

Last updated

2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Risk Assessment

Brief summary

The main objective of this study is to determine how physicians make decisions regarding surveillance of Intraductal Papillary Mucinous Neoplasm's (IPMN) of the pancreas.

Detailed description

The study will employ a survey design that poses physicians with a series of three clinical case vignettes. Each vignette describes an IPMN of varying severity, and the physician will be asked determine whether they would continue or discontinue clinical surveillance in each case. This will be a double-blinded randomized survey study, featuring two arms. Providers will be randomized to either be provided with, or not provided with a risk stratification tool (DART-1) when presented with their clinical case vignettes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Membership in either the PACYFIC or PRECEDE consortiums * Physician with expertise in the management of IPMN * Able and willing to complete survey

Exclusion criteria

* Not a member of either the PACYFIC or PRECEDE consortiums * Not a physician with expertise in the management of IPMN

Design outcomes

Primary

Measure	Time frame
Number of Decisions to Stop Surveillance Imaging	Day 1
Number of Decisions to Continue Surveillance Imaging	Day 1

Countries

United States

Outcome results